Zdrowie i gospodarka · 02/05/2006

FDA Releases Draft Revised Guidance on Pharmacovigilance of Veterinary Medicinal Products

The Food and Drug Administration (FDA) has released a draft revised guidance for the pharmaceutical industry on managing adverse event reports for veterinary medicinal products. The guidance, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), aims to standardize the reporting of adverse events in the European Union, Japan, and the United States.